The deryosination / retyrosing cycle is the most common post-translational modification of α-tubulin. Interestingly, for plants, the only qualified candidates of potential counterparts TTL are
Read More
We conduct exploratory biomarker study of a phase II clinical trial of eribulin plus gemcitabine (EG) versus paclitaxel plus gemcitabine (PG) in metastatic breast cancer
Read More